Evidence map›Paper›PMID 28135360›Full record

ArticleJAMA neurology2017

Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Ethan Meltzer, Peter V Sguigna, Adnan Subei, Shin Beh, Eric Kildebeck, Darrel Conger, Amy Conger, Marlen Lucero, Benjamin S Frohman, Ashley N Frohman and 8 more

Open access · greenAbstract read
In one paragraph

Article in JAMA neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Ocular Health ofFrontiers in integrative neuroscience · 2021
    Article
  11. Article
  12. Review
  13. Standards in Pupillography.Frontiers in neurology · 2019
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study.Multiple sclerosis journal - experimental, translational and clinical
    Article
  19. Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease.Multiple sclerosis journal - experimental, translational and clinical
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Ethan MeltzerDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Peter V SguignaDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Adnan SubeiDepartment of Neurology, Michigan State University, East Lansing.
Shin BehDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Eric KildebeckDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas3Center for Engineering Innovation, University of Texas at Dallas.
Darrel CongerDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Amy CongerDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Marlen LuceroStudent, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Benjamin S FrohmanStudent, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Ashley N FrohmanStudent, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Shiv SaidhaDepartment of Neurology, Johns Hopkins Hospital, Baltimore, Maryland.
Steven GalettaDepartment of Neurology, Population Health, New York University School of Medicine, New York.
Peter A CalabresiDepartment of Neurology, Johns Hopkins Hospital, Baltimore, Maryland.
Robert RennakerDepartment of Bioengineering, University of Texas at Dallas.
Teresa C FrohmanDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas.
Randy H KardonDepartment of Ophthalmology, University of Iowa, Iowa City9Iowa City Veterans Affairs Center for Prevention and Treatment of Visual Loss, Iowa City.
Laura J BalcerDepartment of Neurology, Population Health, New York University School of Medicine, New York10Department of Ophthalmology, New York University School of Medicine, New York.
Elliot M FrohmanDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas7Department of Bioengineering, University of Texas at Dallas11Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas.
The University of Texas Southwestern Medical Center · USJohns Hopkins Hospital · USNew York University · USUniversity of North Texas at Dallas · USMichigan State University · USSouthwestern Medical Center · USUniversity of Iowa · US

Funding

Novel Clinical and Ocular Imaging Outcomes with Long-Term Follow-Up in MSR01EY019473 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BALCER, LAURA · 2009 to 2010
$1.3M
Longitudinal Assessment of Visual Function in MSR01EY014993 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BALCER, LAURA · 2003 to 2007
$891k
NEI NIH HHS R01 EY014993NEI NIH HHS R01 EY019473
6 · The paper itself

Abstract

Importance: A neurophysiologic signature of the melanopsin-mediated persistent constriction phase of the pupillary light reflex may represent a surrogate biomarker for the integrity of the retinohypothalamic tract, with potential utility for investigating alterations in homeostatic mechanisms associated with brain disorders and implications for identifying new treatments. Objective: To characterize abnormalities of retinal architecture in patients with multiple sclerosis (MS) and corresponding alterations in the melanopsin-mediated sustained pupillary constriction response. Design, Setting, and Participants: The case-control study was an experimental assessment of various stimulus-induced pupillary response characteristics and was conducted at a university clinical center for MS from September 6, 2012, to February 2015. Twenty-four patients with MS (48 eyes) and 15 individuals serving as controls (30 eyes) participated. The melanopsin-mediated, sustained pupillary constriction phase response following cessation of a blue light stimulus was compared with the photoreceptor-mediated pupillary constriction phase response following cessation of a red light stimulus. Optical coherence tomography was used to characterize the association between pupillary response characteristics and alterations in retinal architecture, specifically, the thickness of the retinal ganglion cell layer and inner plexiform layer (GCL + IPL). Main Outcomes and Measures: Association of pupillary response characteristics with alterations in retinal architecture. Results: Of 24 patients with MS included in the analysis, 17 were women (71%); mean (SD) age was 47 (11) years. Compared with eyes from individuals with MS who had normal optical coherence tomography-derived measures of retinal GCL + IPL thickness, eyes of patients who had GCL + IPL thickness reductions to less than the first percentile exhibited a correspondingly significant attenuation of the melanopsin-mediated sustained pupillary response (mean [SD] pupillary diameter ratios at a point in time, 0.18 [0.1] vs 0.33 [0.09]; P < .001, generalized estimating equation models accounting for age and within-patient intereye correlations). Conclusions and Relevance: In this case-control study, attenuation of the melanopsin-mediated sustained pupillary constriction response was significantly associated with thinning of the GCL + IPL sector of the retina in the eyes of patients with MS, particularly those with a history of acute optic neuritis. Melanopsin-containing ganglion cells in the retina represent, at least in part, the composition of the retinohypothalamic tract. As such, our findings may signify the ability to elucidate a putative surrogate neurophysiologic signature that correlates with a constellation of homeostatic mechanisms in both health and illness.

Indexed as

Rod OpsinsAdultCase-Control StudiesFemaleHumansHypothalamusMaleMelanopsinMiddle AgedMultiple SclerosisNeural PathwaysPupil DisordersReflex, PupillaryRetinal Ganglion CellsRetinal NeuronsTomography, Optical CoherenceMelanopsinRod Opsins

Identifiers

PMID28135360
PMCPMC5822208
OpenAlexW2582442262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.